State-of-the-art treatment for children and adolescents with blood diseases
The state-of-the-art, team-based program provides treatment for a broad range of clinical ailments including:
- Anemias, thrombocytopenias and neutropenias
- Congenital and acquired bleeding disorders
- Hemoglobin disorders, including sickle cell anemia and thalassemia
- Aplastic anemia and other bone marrow failure syndromes
- Hypercoagulation syndromes and thrombotic disorders
The hematology team has developed and implemented a comprehensive series of clinical practice guidelines to ensure patients receive the best possible care for conditions that include immune thrombocytopenic purpura, hemophilia and bleeding disorders, sickle hemoglobinopathies and lead poisoning. Renowned for our research and therapies for blood disorders, Texas Children’s Hematology Center physicians conducts state-of-the-art clinical and scientific research aimed at understanding, preventing and curing blood diseases. Our center is associated with Baylor College of Medicine, one of the top medical schools in the country, and Texas Children's Hospital, the largest pediatric hospital in the United States. Texas Children's Hematology Center is dedicated to the integration of laboratory and clinical research to increase our understanding of blood disorders, and to develop new, more effective therapies for children who suffer from hematologic malignancies.